873 results on '"Tamaoka, Akira"'
Search Results
2. Cynomolgus macaque model of neuronal ceroid lipofuscinosis type 2 disease
3. Amyloid-β oligomers interact with NMDA receptors containing GluN2B subunits and metabotropic glutamate receptor 1 in primary cortical neurons: Relevance to the synapse pathology of Alzheimer’s disease
4. Randomized phase 2 study of perampanel for sporadic amyotrophic lateral sclerosis
5. Reduced CSF orexin levels in rats and patients with systemic inflammation: a preliminary study
6. rAAV8 and rAAV9-Mediated Long-Term Muscle Transduction with Tacrolimus (FK506) in Non-Human Primates
7. Transient Hemichorea-hemiballism Induced by a Combination of Postprandial Hypotension and Severe Stenosis of the Innominate Artery Concomitant with Left Carotid Occlusion
8. Splice-site mutations in KIF5A in the Japanese case series of amyotrophic lateral sclerosis
9. Cybernic treatment with wearable cyborg Hybrid Assistive Limb (HAL) improves ambulatory function in patients with slowly progressive rare neuromuscular diseases: a multicentre, randomised, controlled crossover trial for efficacy and safety (NCY-3001)
10. Transcriptome analysis of gravitational effects on mouse skeletal muscles under microgravity and artificial 1 g onboard environment
11. GDF-15, a mitochondrial disease biomarker, is associated with the severity of multiple sclerosis
12. ADAR2-dependent A-to-I RNA editing in the extracellular linear and circular RNAs
13. Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan; 2nd report QOL survey
14. TFEB-mediated Enhancement of the Autophagy-lysosomal Pathway Dually Modulates the Process of Amyloid β-Protein Generation in Neurons
15. Vestibular dysfunction as cortical damage with amyotrophic lateral sclerosis
16. Random Skin Biopsies Before Brain Biopsy for Intravascular Large B-Cell Lymphoma
17. Pathogenic Potential of Eomesodermin‐Expressing T‐Helper Cells in Neurodegenerative Diseases.
18. Nationwide survey of patients with multisystem proteinopathy in Japan.
19. Two Phase 3 Trials of Gantenerumab in Early Alzheimer’s Disease
20. Steroid pulse therapy of radiological disease activity without clinical relapse in CLIPPERS
21. Highly Efficient Ultracentrifugation-free Chromatographic Purification of Recombinant AAV Serotype 9
22. The effect of truncation on prion-like properties of α-synuclein
23. Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan
24. High-sensitivity quantitative analysis reveals the non-linear relationship between the dose and deposition of diphenylarsinic acid in the rat central nervous system following its subchronic exposure
25. Remarkable clinical responses of non-fluctuating Parkinson’s disease (PD) after alternating catechol O-methyltransferase inhibitors: case series switching from entacapone 200 ~ 300 mg/day to opicapone 25 mg/day
26. Fisher syndrome as an immune-related adverse event after using pembrolizumab but not nivolumab
27. The CHC22 clathrin-GLUT4 transport pathway contributes to skeletal muscle regeneration.
28. The immunoreceptor adapter protein DAP12 suppresses B lymphocyte–driven adaptive immune responses
29. Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer’s disease
30. Clinical investigation of segmental zoster paresis: A case of rare motor complications of herpes zoster
31. The neuroprotective effect of perampanel in lithium-pilocarpine rat seizure model
32. Transforming growth factor-β1 in the cerebrospinal fluid of patients with distinct neurodegenerative diseases
33. Neuron-specific analysis of histone modifications with post-mortem brains
34. Correction to: Remarkable clinical responses of non-fluctuating Parkinson’s disease (PD) after alternating catechol O-methyltransferase inhibitors: case series switching from entacapone 200 ~ 300 mg/day to opicapone 25 mg/day
35. Familial cerebral cavernous malformation presenting with epilepsy caused by mutation in the CCM2 gene: A case report
36. Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy
37. Characteristics of hypersomnia due to inflammatory demyelinating diseases of the central nervous system
38. Glutamine/arginine site-unedited GluA2 mRNA in cerebrospinal fluid as a biomarker for amyotrophic lateral sclerosis
39. The identified clinical features of Parkinson's disease in homo-, heterozygous and digenic variants of PINK1
40. α-Synuclein Fibrils Exhibit Gain of Toxic Function, Promoting Tau Aggregation and Inhibiting Microtubule Assembly
41. Ultracentrifugation-free chromatography-mediated large-scale purification of recombinant adeno-associated virus serotype 1 (rAAV1)
42. Chronic myelitis associated with zoster sine herpete: A case report
43. Intravascular large B-cell lymphoma presenting with hearing loss and dizziness: A case report
44. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review
45. Dentatorubropallidoluysian Atrophy with Prominent Autonomic Dysfunction
46. Long-term accumulation of diphenylarsinic acid in the central nervous system of cynomolgus monkeys
47. Topographical disorientation in a patient with right parahippocampal infarction
48. 右視野欠損，幻視を呈し，てんかん重積状態を来した抗GAD抗体関連脳炎の1症例
49. Detection of diphenylarsinic acid and its derivatives in human serum and cerebrospinal fluid
50. Hypothyroidism induced by phenytoin and gabapentin: A Case Report
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.